Opinion: Trade agreement drug monopoly is obsolete given faster, better drug discovery
For decades, the brand-name drug industry has relentlessly promoted the message that any reduction in…
Author: STAT
STAT Plus: At Biogen, drug developer Al Sandrock gets a chance to take his shot
Biogen announced Tuesday that its R&D chief is leaving for a venture capital firm and…
Report: DEA did too little to constrain opioid supply even as crisis escalated
WASHINGTON — The Drug Enforcement Administration fell dramatically short in regulating the prescription opioid supply…
STAT Plus: Biotech incubator LabCentral to double its space in Boston
LabCentral, the biotech incubator in Cambridge, Mass., that has nurtured dozens of startups in a…
STAT Plus: Novartis partners with Microsoft to use AI in drug development
Novartis and Microsoft have inked a five-year deal to use artificial intelligence to design molecules,…
STAT Plus: Pharmalittle: A novel plan to settle opioid suits; AstraZeneca COPD drug gets thumbs-down
Good morning and welcome to October. Elizabeth Cooney sitting in for Ed Silverman again today…
Opinion: Governments should fight air pollution from fossil fuels like they fight tobacco use
Imagine driving into a gas station to fill up your car’s gas tank and seeing…
Opinion: FDA’s research guidance will help take guesswork out of drug dosing in newborns
When we need to give medicine to newborns in our hospital, we often have to…
STAT Plus: Pharmalittle: Step forward for ovarian cancer drugs; Pelosi’s drug pricing plan could hit hospitals hard
Good morning. Elizabeth Cooney here, subbing for Ed Silverman today and tomorrow from a satellite…
Opinion: Science publications should use checklists, badges to signal trustworthiness
Most of us rely on vetted experts, brand names, seals of approval, and other signals…
Opinion: AI needs patients’ voices in order to revolutionize health care
Patients’ stories — what doctors call patient histories — are the bedrock of medicine. “Listen…
Flu vaccine selections may be an ominous sign for this winter
It’s never an easy business to predict which flu viruses will make people sick the…
STAT Plus: Pelosi’s drug pricing plan could wipe out some key funding for low-income hospitals
WASHINGTON — A 60-word provision tucked into Nancy Pelosi’s signature drug pricing plan could wreak…
Watch: In a quest for more precise cancer care, hospitals invest in new tools — and new training, too
BOSTON — On a recent Wednesday morning at Brigham and Women’s Hospital, a team of…
.jpg)
STAT Plus: AstraZeneca and GSK drugs reduce risk of ovarian cancer returning, studies find
Two different pills reduce the risk of ovarian cancer coming back after surgery and chemotherapy,…
STAT Plus: Amgen’s KRAS-blocking drug shows minimal effect in colon cancer patients
Amgen’s experimental KRAS-blocking drug is showing minimal tumor-shrinking effects in patients with advanced colorectal cancer,…
U.S. alerts travelers to Tanzania about possible unreported Ebola cases
The State Department and the Centers for Disease Control and Prevention are alerting American travelers…
Major error undermines study suggesting change introduced in the CRISPR babies experiment shortens lives
A scientific study published this past spring came with damning implications for Chinese scientist He…
STAT Plus: Avanir to pay $116 million to settle bribery charges, while two docs and former sales reps are indicted
Avanir Pharmaceuticals agreed to pay $116 million to settle civil and criminal charges of allegedly…
Many patients with vaping-related illnesses used THC, CDC reports
Health officials in two states say that many patients sickened by vaping-associated lung illness vaped…
STAT Plus: Mylan pays $30 million to settle charges of misleading investors over probe into EpiPen Medicaid rebates
In the latest fallout from the EpiPen pricing scandal, Mylan (MYL) agreed to pay $30…
Feds take down alleged Medicare gene test fraud that peddled cheek swabs
WASHINGTON — Federal agents took down an alleged Medicare fraud scheme Friday that exploited seniors’…
STAT Plus: Pharmalittle: House hearing on drug pricing descends into chaos, EMA tells drug makers to test for impurities
Rise and shine, everyone, another busy day is on the way. Most days are busy,…
FDA clarifies how it will regulate digital health and artificial intelligence
The U.S. Food and Drug Administration has issued new guidelines on how it will regulate…
STAT Plus: Moderna will give Harvard researchers access to its RNA technology
Moderna — once “obsessed with secrecy” — is about to give some of its technology…
23andMe, moving beyond consumer DNA tests, is building a clinical trial recruitment business
SAN FRANCISCO — Consumer genetics giant 23andMe announced Thursday that it would move deeper into…
Opinion: The industry that cries wolf: pharma and innovation
Drug companies play games. One of them involves product hopping — switching from one version…
A devastating illness rocked Uganda, then disappeared. Disabled children — and a mystery — remain
Two decades ago, in a small pocket of Northern Uganda, something peculiar and tragic started…
STAT Plus: California reports pharma increased list prices way above inflation
For the first time since California began requiring drug makers to report and explain their…
STAT Plus: ‘Why don’t you stop talking?’ Hearing on Pelosi’s drug pricing plan mired by partisan bickering
WASHINGTON — Just months after lawmakers on the Energy and Commerce Committee lavished praise on…
FDA ‘should have acted sooner’ on e-cigarettes, agency head tells Congress
The Food and Drug Administration “should have acted sooner” to rein in the e-cigarette industry…
STAT Plus: U.K.’s Corbyn promises to form a government-owned drug company to lower prices
In a potential challenge to the pharmaceutical industry, Jeremy Corbyn promised that if his opposition…
STAT Plus: Pharmalittle: Drug pricing overhaul appears less likely; FDA to review drug given accelerated approval
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
STAT Plus: First it was aspirin, then Xarelto. What’s Bayer’s next big thing?
Originally, aspirin might have come from a bitter-tasting extract of the willow tree — but…
Opinion: As tariffs affect the pharma industry, business strategies must evolve
The trade conflict with China seems to escalate, although it can change with a tweet….
Opinion: Trump’s trade war is hurting companies like mine — and the biotechnology industry
Many industries have been affected by the Trump administration’s escalating trade war, from agriculture to…
‘I just want to live’: California man pleads with scientists around the world to ‘CRISPR me’
On one level, Malakkar Vohryzek always knew what was wrong with him. For as long…
STAT Plus: U.K. regulator supports off-label use of the Avastin cancer drug for a serious eye condition
The U.K. medicines regulator determined that reformulating the Avastin cancer medicine into a treatment for…
.jpg)
STAT Plus: FTC warns lawyers about deceptive ads for generating lawsuits over drug side effects
After years of complaints, the Federal Trade Commission has sent letters to lawyers to warn…
STAT Plus: Bayer to invest in Boston lab focused on chronic lung conditions
German pharmaceutical giant Bayer AG will invest more than $30 million over the next five…
STAT Plus: Novartis unit says FDA wasn’t told of data manipulation sooner because it was ‘highly complex’
If you were wondering why Novartis (NVS) waited more than three months to notify the…
Opinion: Kudos to Google for banning stem cell ads. Other tech companies should follow
Google took an important step this month toward restricting the reach of one breed of…
STAT Plus: Pharmalittle: Pelosi plan rests with Dems who get big pharma bucks; Novartis recalls heartburn meds from U.S.
Rise and shine, everyone, another busy day is on the way. We can tell because…
STAT Plus: Novartis expands recall of heartburn meds to U.S. after finding carcinogen
After running tests, the Sandoz unit of Novartis (NVS) has expanded its recall of heartburn…
STAT Plus: Antibiotic resistance in food-producing animals surges in low- and middle-income countries
As concern mounts over the use of medically important antibiotics given to food-producing livestock, a…
Opinion: Patients will be the losers as Pelosi’s plan to control drug prices nearly strikes out
This year has brought new treatments for osteoporosis, advanced bladder cancer, Ebola, tuberculosis, spinal muscular…
STAT Plus: Akcea, a biotech that relies on gene-blocking tech, loses its three top executives in one fell swoop
Three executives at Akcea Therapeutics (AKCA) are out less than a year after the company…
STAT Plus: Pharmalittle: More countries restrict heartburn meds; Novartis battles Belgium over gene therapy for a toddler
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT Plus: More countries are banning or restricting sales of Zantac and other heartburn meds
More than a dozen countries around the world are taking steps to restrict or ban…
STAT Plus: RA Capital launches Carnot, an incubator for early-stage biotechs
Noted biotech investment firm RA Capital has quietly launched an incubator program. The incubator, called…